Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
06/2003
06/26/2003WO2003052091A1 Growth factor modified protein matrices for tissue engineering
06/26/2003WO2003052089A1 Disruption of the glutathione s-transferase-omega-1 gene
06/26/2003WO2003052085A1 Dermal replacement prepared from mesenchymal cells of hair follicle
06/26/2003WO2003052084A2 Cell constructs cultured in vitro, preparation and uses
06/26/2003WO2003052083A2 Methods for the generation of proliferating and differentiating cell lines
06/26/2003WO2003052082A2 Fusion partner cells and uses thereof
06/26/2003WO2003052080A2 Pluripotent stem cells derived without the use of embryos or fetal tissue
06/26/2003WO2003052078A2 Insect g protein-coupled receptor genes and uses thereof
06/26/2003WO2003052065A2 Antisense modulation of b-cell associated protein expression
06/26/2003WO2003052064A2 Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
06/26/2003WO2003052057A2 Egvi endoglucanase and nucleic acids encoding the same
06/26/2003WO2003052056A2 Egviii endoglucanase and nucleic acids encoding the same
06/26/2003WO2003052055A2 Egvii endoglucanase and nucleic acids encoding the same
06/26/2003WO2003052054A2 Bgl5 beta-glucosidase and nucleic acids encoding the same
06/26/2003WO2003052052A2 Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor
06/26/2003WO2003052051A2 Adeno-associated virus (aav) serotype 8 sequences
06/26/2003WO2003052050A2 P450 enzymes, nucleic acids encoding them and methods of making and using them
06/26/2003WO2003052049A2 Molecules for disease detection and treatment
06/26/2003WO2003052048A2 Nucleic acid-associated proteins
06/26/2003WO2003052047A1 Device for active phase cell or tissue sampling and uses thereof
06/26/2003WO2003051928A1 Antibody specific for detection of bradeion
06/26/2003WO2003051927A2 Production of f(ab')2 fragments in mammalian cells
06/26/2003WO2003051923A2 Novel g-protein coupled receptors and dna sequences thereof
06/26/2003WO2003051921A1 Chemokine mutants acting as chemokine antagonists
06/26/2003WO2003051917A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
06/26/2003WO2003051907A2 Method of enhancing immunogenicity by covalent linkage of antigens to proteins on the surface of dendritic cells
06/26/2003WO2003051720A2 A myeloma cell line useful for manufacturing recombinant proteins in chemically defined media
06/26/2003WO2003051419A1 Skin/hair equivalent with reconstructed papillae
06/26/2003WO2003051350A1 Use of lipoxin analogs to promote cell defense against gram-negative infections
06/26/2003WO2003051308A2 Antisense modulation of tfap2c expression
06/26/2003WO2003051285A2 Therapeutic anti-hiv (iv9) compounds
06/26/2003WO2003051283A2 Engineered bone marrow
06/26/2003WO2003051111A2 Cryopreservation of biological materials using pre-chilled protectant
06/26/2003WO2003035678A3 Sperm factor sequences
06/26/2003WO2003026396A3 Transgenic mice containing socs-5 cytokine signalling suppressor gene disruptions
06/26/2003WO2003024989A3 Activation and expansion of cells
06/26/2003WO2003020005A3 Lp mammalian proteins; related reagents
06/26/2003WO2002046385A3 Enzymes
06/26/2003WO2002032378A9 Fusion cells and cytokine compositions for treatment of disease
06/26/2003WO2002018608A3 Methods for enhancing the efficacy of cancer therapy
06/26/2003WO2002016944A3 Synthetic nucleic acid molecule compositions and methods of preparation
06/26/2003WO2002016597A3 Lipid metabolism enzymes
06/26/2003WO2002006529A3 Detection and treatment of polycystic kidney disease
06/26/2003WO2002004493A3 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
06/26/2003US20030121073 Use of acetoacetyl-CoA thiolase for identifying new fungicidally active substances
06/26/2003US20030121067 V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto
06/26/2003US20030121066 Transgenic mice containing SOCS-5 cytokine signalling suppressor gene disruptions
06/26/2003US20030121065 Polyfunctional base sequence and artificial gene containing the same
06/26/2003US20030121064 CNS neuroregenerative compositions and methods of use
06/26/2003US20030120059 Cell surface molecule-induced macrophage activation
06/26/2003US20030120058 Polypeptides; proteolysis splitting; antitumor agents
06/26/2003US20030120054 Modified Cry3A toxins and nucleic acid sequences coding therefor
06/26/2003US20030120053 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030120043 Tumor necrosis factor receptor-associated factors
06/26/2003US20030120038 Inhibitor of vascular endothelial cell growth factor
06/26/2003US20030119905 Contacting the bone marrow with an inhibitor of nitric oxide synthase, to produce bone marrow having an increased population of hematopoietic stem cells capable of normal hematopoiesis and differentiation
06/26/2003US20030119896 Chondrogenesis promoters and indolin-2-one derivatives
06/26/2003US20030119891 Polylactam oligomers of N-methyl-2-carboxy-4-imidazole, N-methyl-2-carboxy-4-aminopyrrole modified by 4-aminobutyric acid, 3-amino-propionic acid and 3-(dimethylamino)propylamine binding specifically to the cyclogenase 2 gene
06/26/2003US20030119771 Especially inducers of osteoblast differentiation
06/26/2003US20030119729 Promoting survival of substantia nigra neuronal cells by contacting with a trophic amount of a ptc therapeutic; mimics hedgehog-mediated patched signal transduction; treating or preventing Parkinson's Disease
06/26/2003US20030119726 P-glycoproteins and uses thereof
06/26/2003US20030119717 Synergistic activation of regulatory elements by rel proteins and a steroid receptor
06/26/2003US20030119690 Multiply-substituted protease variants
06/26/2003US20030119192 Complementing cell lines
06/26/2003US20030119191 Compositions and methods for helper-free production of recombinant adeno-associated viruses
06/26/2003US20030119187 Antigen presenting cells, method for their preparation and their use for cancer vaccines
06/26/2003US20030119186 Three-dimensional crosslinked gel matrices
06/26/2003US20030119185 Activation and expansion of cells
06/26/2003US20030119184 Cells seeded hollow fibers; ultrafiltration
06/26/2003US20030119183 Processes for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
06/26/2003US20030119182 Immunotherapy; genetic engineering; anticancer agents
06/26/2003US20030119168 Diagnosis of anticancer agents using nucleic acids
06/26/2003US20030119158 Polynucleotide compositions encoding broad-spectrum delta endotoxins
06/26/2003US20030119157 Uniform pore size; adding solution to a organic solvent of low temperature; freeze-drying; phase separation; superior in cell attachment, biocompatibility, and biodegradability
06/26/2003US20030119149 Fusion protein capable of forming a trimer; nonimmunogenic; modulates signaling of tumor necrosis family receptors
06/26/2003US20030119148 Amino-terminally truncated rantes as chemokine antagonists
06/26/2003US20030119146 Novel nucleic acids and polypeptides which resemble Rho and which interact with cell signalling pathways and proteins
06/26/2003US20030119142 Of given sequence; proteins used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors
06/26/2003US20030119141 Of given sequence; proteins used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors
06/26/2003US20030119140 Of given sequence; proteins used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors
06/26/2003US20030119139 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119138 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119137 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119136 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119133 Of given sequence; proteins used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors
06/26/2003US20030119132 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119131 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119130 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119129 Of given sequence; proteins used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors
06/26/2003US20030119126 Of given sequence; proteins used in modulating cell proliferation, inducing neovascularization and diagnosis of tumors
06/26/2003US20030119125 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119124 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119123 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119122 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119120 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119119 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/26/2003US20030119117 Fusion proteins; binding to antibodies
06/26/2003US20030119112 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
06/26/2003US20030119111 G-protein coupled receptor, named 2871 receptor
06/26/2003US20030119110 Secreted and transmembrane polypeptides and nucleic acids encoding the same